| Literature DB >> 20875106 |
Paloma Encinas1, Miguel A Rodriguez-Milla, Beatriz Novoa, Amparo Estepa, Antonio Figueras, Julio Coll.
Abstract
BACKGROUND: Despite rhabdoviral infections being one of the best known fish diseases, the gene expression changes induced at the surface tissues after the natural route of infection (infection-by-immersion) have not been described yet. This work describes the differential infected versus non-infected expression of proteins and immune-related transcripts in fins and organs of zebrafish Danio rerio shortly after infection-by-immersion with viral haemorrhagic septicemia virus (VHSV).Entities:
Mesh:
Substances:
Year: 2010 PMID: 20875106 PMCID: PMC2997011 DOI: 10.1186/1471-2164-11-518
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Photograph of one example of hemorrhages in the fins of VHSV-infected zebrafish (A) and time course of mortalities of VHSV-infected zebrafish (B). Adult zebrafish (n = 10) were infected with 2 × 106 ffu/ml of supernatant from VHSV-07.71 infected EPC cells or virus-free cell cultured medium at 14°C in 50 ml of water. Two hours later they were released into 2 liters aquaria. External hemorrhages were present in all the fish that die. Depending on the fish, hemorrhages first appeared distributed among mouth, lateral or ventral skin and bases of the fins. Figure 1A shows one example which appears in 10-40% of the VHSV-infected zebrafish. Mortalities (Figure 1B) were recorded during the following 30 days in 6 different experiments (different symbols). The vertical arrow indicates the 2-day time at which samples of fins and organs (pooled spleen, head kidney and liver) were harvested for further studies.
Figure 2Representative 2D-DIGE of fin proteins from VHSV- infected (red) and non-infected (green) zebrafish. Protein extracts from zebrafish fins were analyzed by 2D-DIGE. First dimension was performed on an immobilized pH gradient gel (pH 4 to 9). Second dimension was performed on a 10% SDS-PAGE to separate proteins by their molecular weight (10 to 150 KDa). The circled numbers correspond to the spots which were analyzed by MS. About 70% of the spots analyzed could be identified depending on the experiment (Table 1). Left, molecular weight markers. Bottom, pH gradient from 4 to 9.
Differential expression of proteins from fins by 2D-DIGE (Exp1, Exp2 and Exp3) and of their corresponding transcripts by hybridization to oligo microarrays
| Spot n° | Protein Name | Accession Number | ~pI | microarray | ||||
|---|---|---|---|---|---|---|---|---|
| 47 | hmgb1 | 42476233 | 16 | 7.0 | ||||
| 26 | gnb1 (G prot), βpolypep1 | 47087315 | 35 | 5.6 | ||||
| 27 | Annexin A1a | 31419751 | 40 | 6.0 | ||||
| 39 | Annexin 1a | 27762256 | 44 | 6.2 | ||||
| 0 | Annexin A5b | 41107552 | 36 | 5.2 | ||||
| 0 | Annexin 5b | 160773369 | 36 | 5.3 | ||||
| 34 | Glutathion S-Transferase | 18858197 | 16 | 8.2 | ||||
| 32 | Glutathion S-Transferase | 47086689 | 20 | 6.4 | ||||
| 10 | Transferrin | 51859259 | 70 | 6.9 | ||||
| 11 | Hemopexin | 33991748 | 65 | 6.3 | ||||
| 12 | Hemopexin | 33991748 | 65 | 6.5 | ||||
| 24 | Aldolase fructose-bisphosphate | 37595414 | 44 | 8.3 | ||||
| 45 | Triosephosphate isomerase 1b | 47271422 | 18 | 7.1 | ||||
| 29 | GAPDH | 56718619 | 42 | 7.2 | ||||
| 31 | GADPH | 53733367 | 40 | 8.2 | ||||
| 4 | GAPDH | 53733367 | 85 | 5.6 | ||||
| 16 | Alpha enolase 1 | 37681795 | 57 | 6.7 | ||||
| 28 | Ldhb Lactate dehydrogenase | 28277619 | 35 | 6.8 | ||||
| 33 | Carbonic anhydrase | 18858379 | 22 | 7.8 | ||||
| 43 | Malate dehydrogenase | 47085883 | 40 | 7.8 | ||||
| 3 | ATP binding | 51571925 | 85 | 5.5 | ||||
| 0 | ATP synthase | 41152334 | 24 | 7.0 | ||||
| 46 | Creatine kinase | 55716037 | 15 | 6.5 | ||||
| 20 | Creatine kinase | 55716037 | 48 | 6.4 | ||||
| 5 | Creatine kinase | 55716037 | 90 | 5.9 | ||||
| 42 | Keratin 18 | 41351240 | 57 | 5.3 | ||||
| 38 | Keratin type I | 50370316 | 57 | 5.6 | ||||
| 13 | Type II cytokeratin | 18858425 | 59 | 5.1 | ||||
| 50 | Tubulin, gamma assoc protein 2 | 41056243 | 85 | 6.0 | ||||
| 30 | Skeletal alpha-actin (S. aurata) | 6653228 | 38 | 7.9 | ||||
| 21 | Alpha-tropomyosin | 18859505 | 44 | 6.6 | ||||
| 0 | Alpha-tropomyosin | 55962544 | 36 | 5.0 | ||||
| 15 | Transgelin | 37681953 | 49 | 5.2 | ||||
| 22 | Kinesin-like protein | 50055013 | 50 | 6.7 | ||||
| 41 | Myosin VIa | 10116291 | 114 | 5.9 | ||||
| 0 | Myosin, light chain 2 | 18859049 | 22 | 5.0 | ||||
| 19 | CapG | 29612467 | 48 | 5.3 | ||||
| 0 | Actin capping protein | 41053959 | 34 | 5.7 | ||||
| 6 | Scinderin | 42542770 | 80 | 6.4 | ||||
| 7 | Scinderin | 42542770 | 80 | 6.5 | ||||
| 17 | Cyclase-associated protein-1 | 37725381 | 58 | 8.3 | ||||
| 35 | Dynamin 1-like | 41055508 | 5 | 5.3 | ||||
| 48 | Semaphorin 3Gb | 57790316 | 7 | 6.4 | ||||
| 14 | CkII protein | 39645432 | 65 | 5.3 | ||||
| 0 | fgf20 fin regeneration | 51571925 | 26 | 6.2 | ||||
| 0 | fgf20 fin regeneration | 51571925 | 26 | 6.9 | ||||
| 0 | fgf20 fin regeneration | 51571925 | 26 | 7.0 | ||||
| 0 | fgf20 fin regeneration | 51571925 | 26 | 7.2 | ||||
Exp1, experiment 1. Exp2, experiment 2. Exp3, experiment 3. Spot n°, number of spot selected in the 2 D gel of Exp1 (Figure 2) for mass spectrophotometry (MS) identification. 0, numbers of spots selected in 2 D gels of exp 2 or 3 (not shown). Gel spots were digested with trypsin and their peptides identified by MS. The corresponding detected proteins with a 100% of probability score of identification are shown grouped by their function. *, spots hypothetically identified by their apparent molecular weight (MW) and isoelectric point (IP) in their respective 2 D gels. ---, spots too faint to be quantified. ~MW and ~PI, apparent molecular weight (MW) and isoelectric points (IP) in the 2 D gel. Accession number of the identified protein sequences in the protein bank. Fold, calculated by the DeCyder-differential in-gel analysis software by the formula, volume of the spot in the VHSV-infected fin/volume of the spot in the non-infected fin. The spots on Figure 2 which have no corresponding description on Table 2 could not be identified by MS. Microarray differential expression data was obtained as explained in the legend of Table 3. Because most of the protein genes appeared several times in the microarray, their corresponding folds were calculated as the means for each of their data (n = 3-10). NF, not found annotated in the microarray.
Differential expression of transcripts from fins and organs by Q-PCR arrays.
| fold | ||||
|---|---|---|---|---|
| accession number | long name transcripts | Fins | Organs | |
| NM_001024435 | complement component 9 | |||
| NM_131243 | complement component c3b | |||
| NM_200863 | complement component 8. gamma polypeptide | |||
| NM_001034182 | secreted immunoglobulin domain 4 | |||
| NM_001002363 | CD36 antigen | |||
| NM_212619 | CD9 antigen (p24) | |||
| NM_001020792 | interleukin 22 | |||
| NM_001020789 | interleukin 17d | |||
| NM_131471 | major histocompatibility complex class I UBA gene | |||
| NM_213224 | guanine nucleotide binding protein-like 2 (nucleolar) | |||
| NM_001002397 | guanine nucleotide binding protein gamma 7 | |||
| NM_152980 | macrophage stimulating 1 hepatocyte growth factor | |||
| NM_131607 | tnfrsf1a-associated via death domain | |||
| NM_001110278 | activin receptor IIa | |||
| NM_001039637 | forkhead box P1b | |||
| NM_200154 | soluble liver antigen/liver pancreas antigen. like | |||
| NM_131000 | activated leukocyte cell adhesion molecule | |||
| NM_001040353 | cytokine receptor family member B12 | |||
For each experiment, 10 zebrafish were infected with 2 × 106 ffu of VHSV/ml at 14°C while other 10 zebrafish remained non-infected. RNA was extracted from the fins or organs 2-days after VHSV or mock infection, converted to cDNA and used for the AmpliTaq reaction in 384 well plates containing 2 × 186 selected immune-related zebrafish TaqMan Assays (Applied Biosystems). In each plate, 2 × 3 assays of the rplp0 gene were used for normalization. The mean and their corresponding p (t Student one tail) were then calculated from 5 experiments. The transcripts from either fins and/or organs with >2-fold and p < 0.05 changes were first tabulated and then the rest of the table was completed with their corresponding calculated fold values in organs and/or fins, respectively. Fold, expression level in VHSV-infected tissue/expression level in non-infected tissue. +, increased. -, decreased. ~, similar. Figure 3 shows the representation of means and standard errors (SE) of all the genes.
Figure 3Differential expression of transcripts from fins and organs detected by the Q-PCR array. The predesigned Q-PCR TaqMan Assays (Applied Biosystems) targeting 186 immune-related genes from zebrafish were used to estimate their differential transcript levels. Assay conditions and analysis were as described in methods and Table 2. The Figure shows the means and standard errors (SE) from 5 experiments for the 186 immune-related transcripts. Short names in italics of the most important genes are to the left of the bars. The mean values >2 fold and p < 0.05 are in Table 2.
Differential expression of transcripts from fins and organs by hybridization to the oligo microarray
| fold | ||||
|---|---|---|---|---|
| accession number | long name transcripts | Fins | Organs | |
| NM_131243 | complement component c3b | |||
| P01024 | complement c3 precursor | |||
| NM_001024435 | complement component 9 | |||
| TC319537 | complement component 9 | |||
| TC360850 | complement component 9 | |||
| NM_131338 | complement factor b | |||
| XR_029814 | ~to complement factor b/c2b | |||
| NM_001003496 | complement component 8, alpha polypeptide | |||
| NM_200863 | complement component 8 gamma polypeptide | |||
| TC331566 | complement regulatory plasma protein | |||
| XM_0013357 | ~to complement factor h precursor | |||
| NM_200638 | complement component 6 | |||
| XM_692828 | ~to perforin | |||
| AY494978 | secreted immunoglobulin 4 precursor | |||
| NM_001034182 | secreted immunoglobulin domain 4 | |||
| AF273876 | VH101 immunoglobulin heavy chain variable region | |||
| AF273880 | VH114 immunoglobulin heavy chain variable region | |||
| AF273901 | VHcd9 immunoglobulin heavy chain variable region | |||
| AY646264 | immunoglobulin zeta heavy chain | |||
| AY643752 | immunoglobulin Z heavy chain constant region | |||
| XM_690081 | ~to immunoglobulin epsilon Fc receptor IgE | |||
| XM_001920109 | ~to Polymeric immunoglobulin receptor precursor | |||
| NM_001145630 | leucine-rich repeat Ig-like and transmembrane domains 3 | |||
| XM_001919777 | containing immunoglobulin domains | |||
| NM_001002572 | CD36 antigen | |||
| Q3U490 | CD11c dendritic cells | |||
| NM_152980 | macrophage stimulating 1 hepatocyte growth factor | |||
| NM_152980 | macrophage stimulating 1 hepatocyte growth factor | |||
| NM_001113641 | ~to macrophage-inducible C-type lectin | |||
| Q494Q4 | interleukin-11b. | |||
| NP_998009 | interleukin 1, beta | |||
| NM_001020789 | interleukin 17d | |||
| NM_001018118 | interleukin 15 like (il15l) transcript variant 2 | |||
| NM_001007108 | interleukin 12Ba natural killer cell stimulatory factor 2 | |||
| NM_153660 | interleukin 17 receptor D | |||
| Q6TQH6 | toll-like receptor 7 | |||
| AY389449 | toll-like receptor 5a | |||
| NM_001130594 | toll-like receptor 9 | |||
| NM_131010 | tolloid-like 1 | |||
| NM_001113602 | cytokine receptor-like factor 1b | |||
| NM_200600 | TNF receptor-associated factor 3 interacting protein 1 | |||
| XM_001334668 | ~to TRAF and TNF receptor-associated homolog | |||
| Z46776 | UAA class I MHC | |||
| AJ420954 | MHC class I antigen | |||
| NM_001045563 | novel MHC class I antigen dZ63M10.3 | |||
| NM_205583 | hepcidin antimicrobial peptide 1 | |||
| NM_205583 | hepcidin antimicrobial peptide 1 | |||
| NM_001111083 | interferon 3 | |||
| XM_001344345 | ~to interferon-inducible protein Gig2 | |||
| Q1LVY7 | ~to vertebrate interferon-induced protein 44 | |||
| Q5RI69 | ~to vertebrate selectin L (Lymphocyte adhesion mol 1) | |||
| NM_131426 | lymphocyte enhancer binding factor 1 | |||
| A1L4S5 | cytotoxic T-lymphocyte protein 4. | |||
| XM_001340972 | ~to Perforin-1 precursor (Lymphocyte pore-forming) | |||
| NM_001126448 | leukocyte cell derived chemotaxin 1 | |||
| Q5RJ36 | ~vertebrate lymphocyte adaptor protein | |||
| XM_001336492 | ~to small inducible cytokine A21 | |||
| NM_001030118 | squamous cell carcinoma antigen recognised by T cells 3 | |||
| NM_001030118 | squamous cell carcinoma antigen recognised by T cells 3 | |||
For each experiment, 10 zebrafish were infected with 2 × 106 ffu of VHSV/ml at 14°C while other 10 zebrafish remained non-infected. RNA was extracted from the fins or organs 2-days after VHSV or mock infection, labeled with Cy3 and hybridized to the microarrays. The 636 immune-related selected sequences from the 4x44 K microarray (Appligene) from zebrafish were selected and their data analyzed. In each microarray, 4 assays of rplp0 gene were used for normalization. The mean and p (t Student one tail) were then calculated from 4 experiments. The transcripts from either fins and/or organs with >2-fold and p < 0.05 changes were first tabulated and then the rest of the table was completed with their corresponding calculated fold values in organs and/or fins, respectively. Fold, expression level in VHSV-infected tissue/expression level in non-infected tissue. +, increased. -, decreased. ~, similar. Figure 4 shows the representation of the means of all the immune-related genes.
Figure 4Differential expression of transcripts from fins and organs detected by hybridization to the oligo microarray. The selected 636 immune-related annotated genes from the zebrafish oligo microarray (Agilent) were used to estimate their differential transcript levels. Assay conditions and analysis were as described in methods and Table 3. The Figure shows the means from 4 experiments for the 636 immune-related transcripts. Short names in italics of the most important genes are to the left of the bars. The mean values >2 fold and p < 0.05 are in Table 3.
Figure 5Total numbers of differentially expressed genes from fins and organs detected by Q-PCR and oligo microarrays (A) and differentially increased fin genes by both Q-PCR and oligo microarrays (B). A) Represents the total number of genes increasing > 2-fold with p < 0.05 (Tables 2 and 3) as the percentage of the total number of immune-related genes assayed in Q-PCR (open bars) or oligo microarrays (black bars). Percentages were calculated by the formula, 100 × number of differentially expressed genes/total number of immune-related genes assayed. +, increasing after VHSV infection. -, decreasing after VHSV infection. B) Represents the differential fin transcript levels together with their gene short names that increased >2-fold and p < 0.05 in both Q-PCR and oligo microarrays.